- 中國銀行成立養老金融中心
...
- https://synapse.patsnap.com/drug/c31106a2b765340f946183b903af5fae
- https://synapse.patsnap.com/drug/c6750c78001c4d8180af96150a669046
- https://synapse.patsnap.com/drug/415f516589cd42e1a71b6a95ce9fa0a1
- https://synapse.patsnap.com/article/what-are-gpr75-inhibitors-and-how-do-they-work
- https://synapse.patsnap.com/article/what-are-lims1-inhibitors-and-how-do-they-work
- https://synapse.patsnap.com/drug/b202e9e80aa8437ba8f2d290c9f24e1d
- https://synapse.patsnap.com/drug/8021ea636fb945a89b67111031fb06b4
- https://synapse.patsnap.com/article/orexo-begins-new-ox640-study-in-allergic-rhinitis-patients
- https://synapse.patsnap.com/drug/0b1ce387a0464da2bf60add666f7b43d
- https://synapse.patsnap.com/blog/deep-scientific-insights-on-pegvisomants-randd-progress
点击排行
- 中證紅利全收益再刷曆史新高 紅利資產或仍為後市主線方向
- 押金半年收不回、退款難！聯動雲租車被多地列為失信被執行人
- 中航電測：2023年淨利潤9816.71萬元 同比下降49.05%
- 華平股份：3月14日召開董事會會議
- 國家金融監管總局：把服務新質生產力作為關鍵著力點 加大對建設現代化產業體係的金融支持
- OpenAI首席技術官：Sora將於年內正式向公眾推出 可配備音效、編輯視頻內容
- 商務部：抓緊修訂全國版外資準入負麵清單 實現製造業領域外資準入限製清零
- 汕頭龍湖區送“法”進校園關愛“隨遷子女”
- 直接經濟貢獻340億港元！香港“高才通”計劃獲逾7.2萬宗申請 下半年將迎抵港高峰
- 泰恩康：聚蘭德擬減持不超過1.72%
本周热门
- 東睦股份：業績說明會定於4月29日舉行
- 德宏股份：公司控股子公司浙江鎮能科技有限公司已成立了合同能源管理相關的運營公司
- 新款口服霍亂疫苗進入世衛組織資格預審清單
- 午評：創業板指跌0.42% 傳媒娛樂板塊、Sora概念大漲
- 恩捷股份：合益投資累計質押股數約為9340萬股
- 平治信息：終止向不特定對象發行可轉債事項
- 中國互聯網30周年發展座談會：推進基礎設施現代化 優化算力設施建設布局
- 汽車股領跑 港股消費ETF（513230）漲超2% 理想汽車漲近6%
- 特斯拉被裁員工講述：半夜收到郵件；英偉達一夜蒸發1.4萬億元；比特幣完成第四次減半；亞洲貨幣保衛戰打響|一周事件
- 抖音申請抖音家裝商標
- 陽光乳業2023年穩健增長 持續加大營銷渠道和品牌建設投入
友情链接
- 光算谷歌营销光算谷歌seo光算谷歌推广光算谷歌外鏈光算谷歌seo代运营光算谷歌seo公司光算谷歌外链光算谷歌seo光算谷歌营销光算谷歌外链光算谷歌seo代运营https://synapse.patsnap.com/blog/semaglutide-era-and-the-quest-for-new-weight-loss-therapieshttps://synapse.patsnap.com/article/roche-submits-gazyva-lupus-results-to-fdahttps://synapse.patsnap.com/drug/21a93fb27d25409e9c50136919f90e06https://synapse.patsnap.com/drug/c380857dba304b0bb7b8c28a9f1aacbchttps://synapse.patsnap.com/drug/0c4587f3bd7b41909a04d25132e2b74bhttps://synapse.patsnap.com/article/what-are-the-side-effects-of-ancitabine-hydrochloridehttps://synapse.patsnap.com/article/what-is-cecolin-9-used-forhttps://synapse.patsnap.com/drug/8935d5f0330e4d83a1a4776af91c4d16https://synapse.patsnap.com/drug/eeebb6e29d2d46f2922569af5c62934ehttps://synapse.patsnap.com/drug/5feb822c453744448265359bbab0a37ehttps://synapse.patsnap.com/article/what-is-the-mechanism-of-hydrocortisone-butyratehttps://synapse.patsnap.com/article/indapta-therapeutics-shares-data-on-nk-cell-therapy-at-immunotherapy-meetinghttps://synapse.patsnap.com/drug/fe31205e76f7b75ee6c6e25108591030https://synapse.patsnap.com/article/what-is-eftansomatropin-alfa-used-forhttps://synapse.patsnap.com/drug/19561508c3824bf79b8e0cedaecf86e1https://synapse.patsnap.com/article/pfizer%25E2%2580%2599s-braftovi%25C2%25AE-%252B-mektovi%25C2%25AE-demonstrates-sustained-efficacy-in-braf-v600e-mutant-metastatic-nsclchttps://synapse.patsnap.com/article/what-are-the-therapeutic-candidates-targeting-pd-1https://synapse.patsnap.com/article/what-is-avapritinib-used-forhttps://synapse.patsnap.com/drug/da50fc1d353242adb50382a8076bbeedhttps://synapse.patsnap.com/article/eledon-pharmaceuticals-q1-2024-financial-resultshttps://synapse.patsnap.com/drug/d59dc427ab89499ead9f3c417055028ehttps://synapse.patsnap.com/article/what-is-clarithromycin-used-forhttps://synapse.patsnap.com/article/novo-halts-phase-2-of-forma-acquired-myelodysplastic-drughttps://synapse.patsnap.com/article/what-are-f12-inhibitors-and-how-do-they-workhttps://synapse.patsnap.com/article/fda-approves-rmat-for-poseida%25E2%2580%2599s-car-t-therapy-p-bcma-allo1https://synapse.patsnap.com/drug/6d845a0584f2435cbe36af72105d4542https://synapse.patsnap.com/drug/9495e47e06e4449eaaf02f6753f3ddb4https://synapse.patsnap.com/article/%25CE%25B1-1-adrenergic-receptor-antagonists-lower-lewy-body-dementia-riskhttps://synapse.patsnap.com/drug/e950a8d0c84a40348c49304445f58fa5https://synapse.patsnap.com/drug/c3971a53c8a91cb888d39727c57bcf30